Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pulmonary embolism and deep venous thrombosis during pregnancy or oral contraceptive use: prevalence of factor V Leiden.

American heart journal - 1 Jun 1996

Hirsch D R, Mikkola K M, Marks P W, Fox E A, Dorfman D M, Ewenstein B M, Goldhaber S Z

Abstract excerpt

Activated protein C resistance caused by factor V Leiden mutation is the most common inherited cause of an underlying predisposition to pulmonary embolism (PE) and deep venous thrombosis (DVT). We studied the frequency of the factor V Leiden mutation in 50 women who had PE and/or DVT during or after pregnancy or during oral contraceptive use. Ten (20%; 95% CI 10% to 34%) of the 50 women were heterozygous for the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adolescent
Share to Enzyme Activation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Factor V

Share to Mutation

Share to Polymerase Chain Reaction

Share to Pregnancy

Share to Protein C

Share to Risk Factors

Source

Identifiers

PMID: 8644593
DOI: 10.1016/s0002-8703(96)90089-7

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pulmonary embolism and deep venous thrombosis during pregnancy or oral contraceptive use: prevalence of factor V Leiden.PMID 8644593Read ↗

Thrombotic risk during oral contraceptive use and pregnancy in women with factor V Leiden or prothrombin mutation: a rational approach to contraception.Semantic proximity Read ↗

Factor V Leiden: should we screen oral contraceptive users and pregnant women?Semantic proximity Read ↗

The incidence of the factor V Leiden mutation in an obstetric population and its relationship to deep vein thrombosis.Semantic proximity Read ↗

Factor V Leiden mutation and the risk of venous thromboembolism in pregnant women.Semantic proximity Read ↗

Prevalence of factor V Leiden and prothrombin G20210A mutations in unselected patients with venous thromboembolism.Semantic proximity Read ↗

Are factor V Leiden carriers who use oral contraceptives at extreme risk for venous thromboembolism?Semantic proximity Read ↗

Activated protein C resistance (factor V Leiden) associated with thrombosis in pregnancy.Semantic proximity Read ↗

Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation.Semantic proximity Read ↗

Factor V Leiden and prothrombin 20210 G-A mutations in controls and in patients with thromboembolic events during pregnancy or the puerperium.Semantic proximity Read ↗

Inherited thrombophilia and first venous thromboembolism during pregnancy and puerperium.Semantic proximity Read ↗

Combined oral contraceptives, thrombophilia and the risk of venous thromboembolism: a systematic review and meta-analysis.Semantic proximity Read ↗

Prevalence of factor V Leiden and prothrombin 20210 A variant in Bulgarian patients with pulmonary thromboembolism and deep venous thrombosis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.